Lipedema / GLP-1 medication
Surgery takes the disease out.The medication takes the weight off.
Jeffrey A. Ditesheim, MD, FACS
Written by Dr. Jeffrey A. Ditesheim, MD, FACS · About Dr. Ditesheim
GLP-1 medication does not remove lipedema tissue, but when used before and after surgery under medical supervision, it may help support weight management, reduce overall body fat, and improve long-term health outcomes. My approach to lipedema has changed. For years it was immediate surgery. It is now a combined approach: GLP-1 medication (Ozempic, Wegovy, Mounjaro, and Zepbound) before surgery, surgery to remove the lipedema, and GLP-1 medication again afterward. This page explains why, describes the protocol I now use, and shows my own patients photographed at each step — before surgery, after surgery, and after the medication. I want to be clear at the outset that there are no published studies yet on GLP-1 medication in lipedema. What follows is what I have learned, offered because it has been life-changing for so many of the women I treat.
Three things about this disease made surgery alone the wrong answer for many women.
Lipedema fat cells do not work properly. Fluid collects around them, and the tissue becomes a continuing source of inflammation — the swelling, the pain, the heavy legs. Controlling the inflammatory triggers and their consequences is critical, and before the GLP-1 medications the only anti-inflammatory strategy available was diet modification. These medications appear to have an anti-inflammatory benefit of their own. Very frequently, women taking them describe less functional disability — before anyone has operated on anything.
Many of my patients describe large, uncontrolled weight gain, particularly at times of hormonal flux — puberty, pregnancy, menopause. That extra weight changes the surgery. Removing fifteen to twenty pounds of fat in one procedure is more dangerous and carries more complications than a smaller operation. And a patient over 200 pounds carries greater intrinsic health risks going into any surgery, which means a greater risk of surgical complications coming out of it.
Surgery is the most critical part of treatment because it is the only thing that removes lipedema tissue. But the ordinary obesity fat sitting alongside the disease does not need to be removed surgically. It can be reduced medically with GLP-1 medication. Separating those two jobs is the whole idea.
It may be that patients in Germany, where much of the surgical approach was developed, tend to present at lower weights. When I visited the LipoClinic in Mülheim in 2024, the protocol was still surgery — usually four consecutive procedures — and GLP-1 medication was not being used at all.
More than anything I read, this is what changed my mind.
When these medications arrived, the first thing I noticed was that weight loss on them was very predictable. In my lipedema patients, tirzepatide — which acts on both the GLP-1 and GIP pathways.
It is true that the adoption of GLP-1 medication in lipedema has come before the studies. To date there are no published studies specifically looking at its benefit for lipedema patients. What I can tell you is that, anecdotally and consistently, women describe both weight reduction and a decrease in their inflammatory complaints: better mobility, less swelling, less pain. That consistency, across many patients, is the basis for the combined approach I now use.
1. Treat obesity first. GLP-1 medication to bring total body weight down before any operation — especially weight above 200 pounds.
2. Treat inflammation for three months before surgery. GLP-1 medication continues, and at the same time we address every other inflammatory trigger we can find. Some are intrinsic — inflammatory conditions such as endometriosis or arthritis. Some are extrinsic, and diet is the main one.
3. Treat the lipedema surgically, in fewer sessions. With the ordinary fat and the fluid already reduced, what remains is the disease, and it can be removed more precisely and more safely. After surgery, GLP-1 medication is resumed to control weight and, in my experience, to help control progression of the disease.
A few caveats, stated plainly. This is my approach, and it is based on what is known about the disease and on what I have learned from my own patients. Other lipedema surgeons may treat differently. There are no published studies yet evaluating GLP-1 medication with lipedema, so this is an off-label use at this time. I am not your prescriber, and this page is not a recommendation of any particular product.
This page exists to take one idea a step further than the main lipedema page: to show the same woman before surgery, after surgery, and then after GLP-1 medication at a lower weight, so you can see for yourself what each one does.
The medication reduces weight by shrinking normal fat cells. Surgery removes the lipedema and changes the shape of the limb. My patients put it better than I can: “With the GLP-1 my size decreased. With surgery my shape changed.”
The other thing the photographs show is what does not change. Lipedema tissue is different from normal fat and does not respond to GLP-1 medication. An untreated area with lipedema keeps its shape no matter how much weight comes off. That is why surgery remains the mainstay of treatment for removing the disease — and why, for a woman at 200 to 300 pounds, medication first means a less risky operation, or fewer of them. Several of my patients have also stayed on the medication after surgery as maintenance, to hold their weight and their result.
All photographs are of my own patients, published with consent and shown without retouching. Read each case left to right.
Case 01 · surgery, then GLP-1
142 lb · early-stage lipedema, lower body
132 lb · buttocks, thighs and knees · shape corrected
116 lb. · 9 months later, no further surgery
34
Buttocks, thighs, knees · one session
Surgery, then GLP-1
142 to 116 lb
One year
Significant relief of pain and swelling
The middle frame is what surgery does to shape, at essentially the same weight. The last frame is twenty-six pounds off the medication — and the thing to look at is how little her lower legs move between those two frames.
That is this page in one photograph. The weight came off everywhere the medication could reach. It did not reach the lipedema still in her lower legs, and it never will. She is now on a maintenance dose and we are planning her lower legs as the next area to treat.
Case 02 · two surgeries at high weight, then GLP-1
248 lb · extensive lipedema, lower body (high weight 300 lb)
226 lb · 17 lb of lipedema fat removed
157 lb · six months later; she went on to reach 140 lb
57
Thighs, buttocks, saddlebags, knees · two sessions, four months apart
Two surgeries at high weight, then GLP-1
248 to 140 lb (160 lb total from a high of 300 lb)
Lipedema remains in untreated areas; further surgery planned at lower weight
She had two surgeries. The first treated the anterior thighs and the saddlebags (lateral thighs); the second, four months later, treated the posterior thighs, knees and buttocks. This follows the German protocol for higher-weight women. In total, 39.5 pounds of lipedema fat were removed in two sessions. The first frame is her at 248 pounds — her high weight was 300. The middle frame is 226 pounds, after the first surgery alone removed 17 pounds of lipedema fat. Between the middle and third frames she had her second surgery and started GLP-1 medication; the third frame is six months later, at 157 pounds. She would go on to lose 160 pounds in all, from 300 to 140.
So many women present at very high weight. Lipedema treatment under the German protocol meant removing large volumes of fat in four surgical sessions. This woman lost a very large amount of weight with the benefit of two surgeries and GLP-1 medication. She is significantly better functionally, and you can see her changed body shape. She will have significant skin excess as a consequence. Today, treating her obesity first with GLP-1 medication and then addressing her lipedema surgically may have been a safer and more efficient plan, with less risk and less recovery.
Case 03 · three surgeries, GLP-1 started after the second
180 lb · progressing lipedema, lower extremities
137 lb · three sessions
Medication started after the second operation
44
Buttocks, thighs, knees, legs · three staged sessions
37 lbs. of tissue removed over three sessions, medication first would likely have meant two.
Nine months at 137 lb
Improved function and shape; still managing untreated areas
She presented at 180 pounds with significant pain, swelling and limited mobility, and a large volume of disease. Thirty-seven pounds of tissue cannot come out in one setting under any circumstances, so it was staged.
What I would do differently today. She began the medication after her second operation. Had she started it before the first, the ordinary fat would have come down first, the remaining disease would have been clearly demarcated, and I believe this would have been two operations rather than three. Her case is a fair record of how my own thinking has changed, and I would rather show you that than pretend the sequence was always obvious.
Individual results vary. All photographs are of Dr. Ditesheim’s own patients, published with consent and shown without retouching.
Case 04 · GLP-1 FIRST, THEN SURGERY
One session · 6 lb removed · 185 → 147 lb on GLP-1 before surgery
This is the order I recommend now. On GLP-1 before surgery her weight went from 185 to 147 pounds. Her legs got smaller, but they kept the same shape. That is the lipedema, and it is what surgery removed. At sixteen months she has no pain, full mobility and only occasional swelling, and she is off the medication.
Individual results vary. All photographs are of Dr. Ditesheim’s own patients, published with consent and shown without retouching.
This area generates a lot of questions, and I want to be honest about which ones I cannot answer.
Which medication is best for lipedema — tirzepatide or semaglutide?
Which medication works best, and whether microdosing helps, are not known. No research has compared them in lipedema.
Does microdosing work?
Not known. There are no studies. I would rather say that than present information that does not yet exist.
Can lipedema be controlled for more than two years with combined treatment?
This is the question that matters most, and the one I am watching in my own patients. Surgery alone gave most women relief for up to about two years before the fat regrew and the symptoms returned. Whether a combined anti-inflammatory and surgical strategy holds a result beyond that is what we want to see.
Broader questions about the surgery itself, staging and recovery are answered on the main lipedema page.
No. Lipedema tissue is different from normal fat and does not respond to GLP-1 medication. The medication shrinks normal fat cells, which reduces your overall size. Surgery is what changes your shape, because surgery is what removes the lipedema. My patients describe it as: with the GLP-1 my size decreased; with surgery my shape changed.
In my practice, both. Before surgery, to bring total body weight down — especially above 200 pounds — and to control inflammation for about three months so the operation is safer and needs fewer sessions. After surgery, to maintain weight and, in my experience, to help control progression of the disease.
No. There are no published studies yet evaluating GLP-1 medication in lipedema, and its use in lipedema is off-label. What I describe here is my own approach, based on what is known about the disease and what I have observed in my own patients. Other lipedema surgeons may treat differently.
If your legs did not change when the rest of you did, that is worth an examination. A consultation gives you a diagnosis, a stage, and a plan you can act on — including whether medication before surgery is the right first step for you.
Lipedema Treatment in Charlotte — the main lipedema page
What the research says — ten questions answered from the evidence.
Cost and treatment planning — Fees, what six of my own patients paid, insurance and financing.
Written by Jeffrey A. Ditesheim, MD, FACS · About Dr. Ditesheim · Ditesheim Cosmetic Surgery, 9336 Blakeney Center Drive, Suite 130, Charlotte, NC 28277 · 704-542-8686. This page is educational and is not a substitute for individual medical advice. GLP-1 medication is not an approved treatment for lipedema; its use here is off-label and based on the author’s clinical experience. I do not prescribe these medications as a stand-alone service and this page is not a recommendation of any particular product.
